Whole blood thrombin generation improves the understanding of cirrhotic coagulopathy and predicts clinical outcomes in patients with cirrhosis: a prospective cohort study
A. Zanetto,E. Campello,C. Bulato,R. Willems,J. Konings,M. Roest,S. Gavasso,G. Nuozzi,S. Toffanin,P. Zanaga,P. Burra,F.P. Russo,B. de Laat,P. Simioni,M. Senzolo
DOI: https://doi.org/10.1016/j.dld.2024.01.108
IF: 5.165
2024-02-01
Digestive and Liver Disease
Abstract:Introduction Patients with cirrhosis have an increased thrombin generation (TG) in platelet-poor plasma (PPP). By reflecting the contribution of circulating blood cells, whole blood (WB) TG may allow a more physiological assessment of coagulation, thus improving our understanding of cirrhotic coagulopathy and its clinical implications. Aims We conducted a prospective study to 1) compare WB-TG vs. PPP-TG in cirrhosis; 2) assess whether WB-TG could predict hepatic decompensation, further decompensation/ACLF, bleeding unrelated to portal hypertension and venous thrombosis. Material and methods: Assessment of coagulation included routine tests, factor VIII, natural anticoagulants, PPP-TG and WB-TG (with and without thrombomodulin [TM]). Twenty-five healthy subjects were included as controls. All patients were prospectively followed for up to 1 year. Results We included 183 patients (Child-Pugh A/B/C 71/50/62). In compensated cirrhosis, both PPP-TG and WB-TG indicated an increased TG capacity, as reflected by an endogenous thrombin potential (ETP) significantly higher than controls; in decompensated cirrhosis, PPP-TG indicated a hyper-coagulable state with increased ETP and higher peak height, whereas WB-TG revealed a progressive impairment of TG kinetics and total capacity, resulting in a profound hypo-coagulable state in Child-Pugh C. Median duration of follow-up was 11 months in compensated and 8 months in decompensated patients. In compensated cirrhosis, patients who experienced 1st decompensation had a significantly higher WB-TG than those who did not, whereas in decompensated cirrhosis WB-TG was comparable in patients with vs. without further decompensation/ACLF during follow-up. In decompensated patients, WB-TG was more severely compromised in patients who experienced bleeding complications, whereas no association was found with thrombosis. Conclusions In compensated cirrhosis, a more pronounced hyper-coagulable state, as assessed by WB-TG, indicated a higher risk of decompensation, suggesting that hyper-coagulability may be responsible for cirrhosis progression. In decompensated cirrhosis, contrary to PPP-TG that indicates hypercoagulability, WB-TG reveals a significant hypo-coagulable state, which was associated with bleeding complications.
gastroenterology & hepatology